Why is the 4DMedical share price exploding 40% today?

4DMedical signed a three-year, nationwide contract with I-MED Radiology Network.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • 4DMedical share price rockets 40% 
  • The company announced a three-year contract with I-MED 
  • 4DMedical can now send its lung imaging technology to selected clinics among I-MED’s 250 clinic network 

The 4DMedical Ltd (ASX: 4DX) share price is surging today, up 39.6% after posting gains of as much as 95% in early morning trade.

4DMedical shares closed yesterday at 36 cents and are currently trading for 51 cents.

So what's driving ASX investor interest in the respiratory imaging technology company?

Man pointing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Nationwide contract inked

The 4DMedical share price is rocketing after the company reported it has signed a nationwide contract with I-MED Radiology Network. I-MED has more than 250 clinics across Australia.

The new three-year agreement formalises an existing commercial arrangement between the two companies. 4DMedical is now cleared to send its lung imaging technology to other selected clinics across I-MED's network.

Atop the agreement, the company said its agreed to establish a Lung Centre of Excellence together with I-MED. Employing its ling imaging technology, 4DMedical said the centre will "enable world-class research and development activities to advance diagnostic imaging throughout Australia".

The 4DMedical share price could also be getting a lift from the company's report that the collaboration with I-MED could streamline the adoption processes of its diagnostic imaging technology without requiring extensive pilot programs.

Commenting on the development

4DMedical CEO, Andreas Fouras said:

Expansion of our proven capability nationwide means many more people will be able to access the latest technology in respiratory imaging. Beyond putting our innovative technology in the reach of more people, this deal represents a significant opportunity to drive revenue for the company. Additionally, this agreement creates a framework for the rapid commercialisation of future 4DMedical products.

I-MED CEO Shrey Viranna added, "Activating this arrangement augments I-MED's world-class diagnostic imaging offering through access to 4DMedical's unique functional lung imaging technology."

4DMedical share price snapshot

Despite today's big lift, the 4DMedical share price remains down 59% in 2022. By comparison, the All Ordinaries Index (ASX: XAO) is down 13% year-to-date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman looks nonplussed as she holds up a handful of Australian $50 notes.
Healthcare Shares

Is this one of the best ASX 200 stocks money can buy?

High margins, strong growth, and global expansion have helped this ASX company stand out to me.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Healthcare Shares

Why is this ASX 200 share charging 7% higher today?

This stock is making its shareholders smile on Tuesday. Let's find out why.

Read more »

A patient in a hospital bed is reassured by a doctor.
Healthcare Shares

Here's why Ramsay Health Care shares have been demolishing the stock market

Investors are warming to the healthcare stock’s earnings recovery.

Read more »

Three businesspeople leap high with the CBD in the background.
Healthcare Shares

Telix shares jump 14% on big news

Let's see what this radiopharmaceuticals company has announced this morning.

Read more »

Rede arrow on a stock market chart going down.
52-Week Lows

Why the CSL share price just hit a 9-year low

CSL shares slump to levels last seen in December 2017.

Read more »

A man with a comical look on his face holds his hands in a 'time out' gesture.
Healthcare Shares

Why the Immutep share price is halted today

Immutep shares are frozen as investors await a major trial update.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

This small cap ASX biotech could double in under a year, Bell Potter says

The latest profit was just what the doctor ordered.

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Healthcare Shares

Why CSL shares are rebounding today after falling to an 8-year low

CSL shares rebound after hitting an 8-year low as brokers see a potential upside.

Read more »